CYP11B1基因新突变致11β-羟化酶缺陷症1例家系研究
A study of 11β-hydroxylase defect induced by a novel CYP11B1 gene mutation in one family

DOI: 10.6040/j.issn.1671-7554.0.2017.218

Keywords: 11β-羟化酶缺陷症,基因,突变,先天性肾上腺增生,CYP11B1,
Mutation,Congenital adrenal hyperplasia,11β-hydroxylase deficiency,CYP11B1,Gene

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	许岭翎, 陆召麟, 戴为信,等. 11β- 羟化酶缺陷症 9例临床特征与治疗分析[J]. 中国实用内科杂志, 2007, 27(7): 519-522. XU Lingling, LU Zhaolin, DAI Weixin, et al. Clinical characteristics and treatment of 11 beta-hydroxylase deficiency - report of 9 cases and literature review[J]. Chinese Journal of Practical Internal Medicine, 2007, 27(7): 519-522.
[2]	Matsubara K, Kataoka N, Ogita S, et al. Uniparental disomy of chromosome 8 leading to homozygosity of a CYP11B1 mutation in a patient with congenital adrenal hyperplasia: implication for a rare etiology of an autosomal recessive disorder[J]. Endocr J, 2014, 61(6): 629-633.
[3]	Han TS, Walker BR, Arlt W, et al. Treatment and health outcomes in adults with congenital adrenal hyperplasia[J]. Nat Rev Endocrinol, 2014, 10(2): 115-124.
[4]	刘小荣,张笠,王勇平,等. 实时荧光定量PCR技术的理论研究及其医学应用[J]. 中国组织工程研究与临床, 2010, 14(2): 329-332. LIU Xiaorong, ZHANG Li, WANG Yongping, et al. Theory study and medical application of real-time quantitative polymerase chain reaction[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2010, 14(2): 329-332.
[5]	Speiser PW, White PC. Congenital adrenal hyperplasia[J]. N Engl J Med, 2003, 349(8): 776-788.
[6]	Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients[J]. J Clin Endocrinol Metab, 1983, 56(2): 222-229.
[7]	Wang X, Nie M, Lu L, et al. Identification of seven novel CYP11B1 gene mutations in Chinese patients with 11 beta-hydroxylase deficiency[J]. Steroids, 2015, 100: 11-16. doi: 10.1016/j.steroids.2015.04.003.
[8]	Kaynar M, Sonmez MG, Unlu Y, et al. Testicular adrenal rest tumor in 11-Beta-hydroxylase deficiency driven congenital adrenal hyperplasia[J]. Korean J Urol, 2014, 55(4): 292-294.
[9]	Polat S, Kulle A, Karaca Z, et al. Characterisation of three novel CYP11B1 mutations in classic and non-classic 11beta-hydroxylase deficiency[J]. Eur J Endocrinol, 2014, 170(5): 697-706.
[10]	Menabo S, Polat S, Baldazzi L, et al. Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations[J]. Eur J Hum Genet, 2014, 22(5): 610-616.
[11]	Ben Charfeddine I, Riepe FG, Kahloul N, et al. Two novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11beta hydroxylase deficiency in a Tunisian family[J]. Gen Comp Endocrinol, 2012, 175(3): 514-518.
[12]	Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency[J]. Endocrine, 2017, 55(1): 19-36.
[13]	Desviat LR, Perez B, Ugarte M. Minigenes to confirm exon skipping mutations[J]. Methods Mol Biol, 2012, 867: 37-47. doi: 10.1007/978-1-61779-767-5_3.
[14]	Nguyen HH, Eiden-Plach A, Hannemann F, et al. Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene[J]. J Steroid Biochem Mol Biol, 2016, 155(Part A): 126-134.
[15]	Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: an overview[J]. Am J Med Genet C Semin Med Genet, 2010, 154C(3): 329-334.
[16]	孙首悦,杨曼娜,杨军,等. 11β-羟化酶缺陷症临床和基因型分析[J]. 中华医学杂志, 2011, 91(42): 2999-3002. SUN Shouyue, YANG Manna, YANG Jun, et al. Clinical and genetic analysis of 11β-hydroxylase deficiency[J]. Natl Med J China, 2011, 91(42): 2999-3002.

Full-Text